Phosphasal is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Star Pharmaceuticals, Llc. The primary component is Sodium Phosphate, Monobasic, Monohydrate; Phenyl Salicylate; Hyoscyamine Sulfate; Methylene Blue; Methenamine.
Product ID | 0076-0902_46e28dd2-fd8e-2044-e054-00144ff8d46c |
NDC | 0076-0902 |
Product Type | Human Prescription Drug |
Proprietary Name | Phosphasal |
Generic Name | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2010-09-21 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | Star Pharmaceuticals, LLC |
Substance Name | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; HYOSCYAMINE SULFATE; METHYLENE BLUE; METHENAMINE |
Active Ingredient Strength | 41 mg/1; mg/1; mg/1; mg/1; mg/1 |
Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Activity [MoA],Oxidation-Reduction Agent [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2010-09-21 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-09-21 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 40.8 mg/1 |
SPL SET ID: | bda27303-2ee9-4a80-b049-7ad514f894e8 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0076-0902 | Phosphasal | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
44523-742 | Phosphasal | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
0076-0111 | URIBEL | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
0178-0740 | URIBEL | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
0682-0334 | Urimar-T | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
79043-334 | Urimar-T | methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate |
54859-701 | Urin | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
79043-450 | URO-SP | Methenamine, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, and HYOSCYAMINE SULFATE |
0076-0903 | Ustell | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
44523-743 | Ustell | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PHOSPHASAL 85503898 4168084 Live/Registered |
BIOCOMP PHARMA, INC. 2011-12-27 |